Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

StageZero Life Sciences Corporate Update

Accesswire November 9, 2021

StageZero to Issue Q3 2021 Financial Results and Hold Conference Call on Tuesday, November 16

Accesswire November 9, 2021

StageZero Life Sciences Establishes On-Site Clinic for its Next-Generation Multi-Cancer Blood Test Aristotle(TM) in Richmond, Virginia

Accesswire October 7, 2021

StageZero Life Sciences Announces Commencement of Trading on the OTCQB

Accesswire September 27, 2021

StageZero Life Sciences Completes Acquisition of the Health Clinics Business

Accesswire September 2, 2021

StageZero Life Sciences Announces Q2 2021 Financial Results and Operational Update

Accesswire August 17, 2021

StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited

Accesswire August 16, 2021

StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17

Accesswire August 11, 2021

StageZero Life Sciences Announces Extension of Warrants

Newsfile August 5, 2021

StageZero Life Sciences Appoints Matthew J. Pietras as CFO and COO

Accesswire August 3, 2021

StageZero Life Sciences Provides Update on Planned Acquisition of Health Clinics Limited

Accesswire July 29, 2021

StageZero Life Sciences Announces New Ticker Symbol for OTC Markets

Accesswire July 12, 2021

StageZero Life Sciences Announces Results of Annual and Special Meeting

Accesswire June 30, 2021

StageZero Life Sciences' Annual and Special Meeting Update Presentation Will Be Available Post Meeting

Accesswire June 29, 2021

StageZero Life Sciences Offers Drive-Up, COVID-19 PCR Travel Testing with Results Reported the Same Day

Accesswire June 2, 2021

StageZero Life Sciences Announces Q1 2021 Financial Results and Operational Update

Accesswire May 17, 2021

StageZero to Issue Q1 2021 Financial Results and Hold Conference Call on Monday, May 17

Accesswire May 12, 2021

StageZero Life Sciences Announces Rexall as Retailer for COVID-19 Saliva Test Kits Throughout Canada

Accesswire May 11, 2021

BTV Explores Investment Options in Life Sciences

Newsfile May 6, 2021

StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada

Accesswire May 5, 2021